Avalon 2025 Lab Trend Report: Genetic Testing Rises as Routine Testing Levels Off
| |

Avalon 2025 Lab Trend Report: Genetic Testing Rises as Routine Testing Levels Off

A new report from Avalon Healthcare Solutions highlights a significant rise in genetic and biomarker testing, even as routine diagnostic testing stabilizes. The 2025 Lab Trend Report, now in its fifth year, draws insights from 18 million members across Avalon’s managed population, offering health plans a detailed look at shifting diagnostic trends and associated cost…

|

New Survey: 84% of Respondents Would Participate in a Hospital-at-Home Program In Order To Get Home Sooner

  The survey, sponsored by Vivalink, reveals strong consumer support for flexible care models, indicating a need for home-based care as part of the national healthcare system More than 300 Hospital at Home (HaH) programs have been approved across the country, allowing thousands of patients to be monitored in the comfort of their homes after leaving the…

| | |

OncoHost Launches Study on Biomarkers for Renal Cell Carcinoma

  Kidney Cancer Research Aims to Enhance Metastatic Patient Management by Pinpointing Biomarker to Optimize Clinical Decision-Making OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has launched a research study with Dana-Farber Cancer Institute to identify biomarkers for renal cell carcinoma (RCC), a type of kidney cancer. Immune-checkpoint inhibitor…

| | | | |

PathAI Announces PLUTO: a State-of-the-Art Foundation Model to Enhance AI-powered Pathology Tools

  Foundation models were developed on numerous diverse data and will enable drug discovery and anatomic pathology laboratory use cases PathAI, a global leader in AI-powered pathology, launched Pathology Universal Transformer (PLUTO), a pathology-centric foundation model, to further differentiate their portfolio of products geared towards biopharma and pathology laboratory customers. In machine learning, a foundation…

| |

Veda First to Achieve Third-Party Data Validation from Erdős Institute, Reinforcing Commitment to Accountable AI-Powered Solutions in Healthcare

  Independent Audit Finds Veda’s AI Precision Exceeds 90%, Solving Ghost Networks and Payer Network Attestation Challenges Veda, a healthcare technology company specializing in provider data solutions, has achieved third-party validation from Erdős Institute, an independent organization of university PhDs advancing the fields of Data Science and Machine Learning. Following a blind independent review of…

| |

Forum Ventures Report Equips Healthtech Startups with Industry Insights to Drive Innovation

  The report offers practical advice and unique industry perspectives for early-stage founders aiming to engage with health systems Forum Ventures, an early-stage B2B SaaS fund, accelerator, and venture studio, released a new report entitled The New Landscape Of Healthcare: What Healthtech Startups Need To Know To Win. The report offers an exploration of the…

| |

Trilliant Health Joins Databricks Marketplace to Provide Open Access to Healthcare Datasets

  Trilliant Health offers access to its Provider Directory, making information about America’s 2.9 million providers publicly available Trilliant Health also released its national Demand Forecast, which contains 10-year projections of healthcare utilization by service line and demographic segment. This partnership with Databricks, the data and AI company, enables Databricks customers to access proprietary healthcare datasets to…

| | |

Artificial Intelligence Oversight of Growing Interest to Health Care Executives

  Very few health systems have written formal policies addressing the use of artificial intelligence (AI), and even fewer have policies specific to generative AI, reflecting the rapid advances the solutions have made in health care, according to a new survey from the Center for Connected Medicine at UPMC (CCM). The research comes as AI is drawing…

| | |

Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

  Partnership leveraging MDClone’s ADAMS platform to unlock real-world exploratory research and patient-care improvements in the region MDClone, a data analytics and synthetic data company, has partnered with the University Hospital Basel and a leading life sciences organization to build an infrastructure that will evolve how life sciences and pharma research is performed in the…

MD Revolution and Cardiac Solutions Achieve 50% Reduction in 30-Day Cardiovascular Readmissions Using RevUp Remote Care

  Study shows a sustained readmission rate reduction over the full year MD Revolution, a remote care management solutions for health systems and multi-specialty clinics, along with there partner Cardiac Solutions, achieved a 50% reduction in hospital cardiovascular readmission rates by using RevUp Remote Patient Monitoring and Chronic Care Management as part of their program….